Protease inhibitors: current status and future prospects.
By Donmienne Leung, G. Abbenante, D. Fairlie. Journal of Medicinal Chemistry, 2000
729 citations recorded by the source corpus.
Subfields: Cancer Research, Hematology, Oncology
View Paper: https://www.semanticscholar.org/paper/7aa6e5fcfb74d167187059aad98c4ef45e7af39a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Sean Ekins
- Jordi Mestres
- Bernard Testa
- J. Welsh
- L. Sapinoso
- S. Kern
- Andrew I. Su
- C. Moskaluk
Citations in the corpus
- Characteristics of Plant Proteinase Inhibitors and Their Applications in Combating Phytophagous Insects (2005, neutral): “cell signaling/migration, digestion, fertilization, growth, differentiation, immunological defense, wound healing and apoptosis, have great potential in therapeutic applications (Abdel-Meguid, 2000; Leung et al., 2000).”
- In silico pharmacology for drug discovery: applications to targets and beyond (2007, background): “There has been a brief overview of Cathepsin D in a comprehensive review of protease inhibitors (Leung et al ., 2000).”
- Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. (2001, background): “The serine protease, hepsin, which we and others (16) find up-regulated in all of the primary tumors examined, is a potential drug target (17).”
- Considerations for the design and reporting of enzyme assays in high-throughput screening applications (2014, background): “Proteases are a well-established class of drug targets (Leung et al., 2000) and have received considerable coverage in terms of assay formats and reagent kits.”